GALT
Galectin Therapeutics Inc
3.60$
+0.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 11.3% | – | – | – | 27.8% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -11.3% | – | – | – | -27.8% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 6,273.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10,285.0% | – | – | – | 30,858.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 9,436.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,666.3% | – | – | – | 3,663.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 15,710.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 11,951.3% | – | – | – | 34,522.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -15,710.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -11,951.3% | – | – | – | -34,522.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 421.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,058.8% | – | – | – | 4,791.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -16,052.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -12,496.3% | – | – | – | -33,241.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,837.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -16,052.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -12,496.3% | – | – | – | -33,241.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -15,626.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -11,426.3% | – | – | – | -28,422.2% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.